Immucell Corp (ICCC) Reports Q4 Loss of $0.31
Immucell Corp (NASDAQ: ICCC) reported Q4 EPS of ($0.31). Revenue for the quarter came in at $7.63 thousand, versus $0 reported last year.
For earnings history and earnings-related data on Immucell Corp (ICCC) click here.
